Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06767813 |
| Consolidated Lead Sponsor | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | RECRUITING |
| Registered Enrollment | 80 participants (ESTIMATED) |
| Registered Start Date | 2024-03-19 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Henan Cancer Hospital | Zhengzhou, China | Open Hospital Dossier -> |
| Nanjing Drum Tower Hospital | Nanjing, China | Open Hospital Dossier -> |
| The First Affiliated Hospital Of Soochow University | Suzhou, China | Open Hospital Dossier -> |
| Fudan University Shanghai Cancer Center | Shanghai, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.